Results 191 to 200 of about 6,012,951 (335)

Impact of Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease Over 5 Years. [PDF]

J Am Heart Assoc
Grobler AC, Rwebembera J, Beaton A, Ndagire E, Okello E, Pulle J, Sable C, Sarnacki R, Spaziani A, Steer A.   +9 more
europepmc   +1 more source

Outcomes of Moderate Aortic Regurgitation in Rheumatic Heart Disease Patients Undergoing Mitral Valve Replacement for Severe Mitral Stenosis

Eslam Ebied, Zohra Elghazal, Yosry Mahmoud Thakeb, Mohammad Saeed Gassar, Eslam Elshafey, Lojain M H A Hassan, Mohamed Ismaïl   +6 more
openalex   +1 more source

Glycoengineered Recombinant Alpha1‐Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma‐Derived Protein

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Alpha‐1‐antitrypsin (A1AT) is a multifunctional, clinically important, high‐value therapeutic glycoprotein that can be used for the treatment of many diseases, such as A1AT deficiency, diabetes, graft‐versus‐host disease, cystic fibrosis, and various viral infections. Currently, the only U.S. food and drug administration‐approved treatment for
Frances Rocamora, Chen‐Lin Hsieh, Sanne Schoffelen, Johnny Arnsdorf, Eric A. Toth, Abdul S. Yunus, Thomas E. Cleveland IV, Sara Petersen Bjørn, Mina Ying Min Wu, Noel G. McElvaney, Bjørn Gunnar Rude Voldborg, Thomas R. Fuerst, Nathan E. Lewis   +12 more
wiley   +1 more source

Unmasking Rheumatic Heart Disease in Pregnancy. [PDF]

Cureus
Tumkur Panduranga V, Gorantla A, Pandal P, Richard S, Budzikowski AS.   +4 more
europepmc   +1 more source

Targeting neutrophil extracellular traps in metabolic and immune niche: Nanomaterials for diabetes tissue regeneration

BMEMat, EarlyView.
The effects of NETs on regeneration of various diabetic tissues, and strategies targeting NETs for diabetes tissue regeneration. In the diabetic environment, NETs undergo complex metabolic and immune reprogramming, leading to dynamic changes in antibacterial and proinflammatory functions, and affecting regeneration of multiple systemic tissues.
Xinyi Jiang, Muxin Yue, Kai Mao, Boon Chin Heng, Noor Azlin Yahya, Yunsong Liu, Zheng Li   +6 more
wiley   +1 more source

Primary health care approach to rheumatic heart disease management. [PDF]

S Afr Fam Pract (2004)
Meel R, Kaswa R.
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Artificial intelligence-enhanced electrocardiogram for the detection of rheumatic heart disease. [PDF]

Eur Heart J Digit Health
Bhorat R, Harmon DM, Liu K, Dugan J, Ngo C, Friedman PA, Bagula H, Ntsekhe M, Attia ZI.   +8 more
europepmc   +1 more source

Sequential catalytic nanosystem of carbon dots and uricase integrated with polydopamine for therapy of gouty wound ulceration

BMEMat, EarlyView.
Sequential dual‐catalytic treatment of the gout wound ulceration process by CDs‐Uri@PDA. (a) Synthesis steps and morphology of CDs‐Uri@PDA. (b) Sequential treatment process and mechanism of CDs‐Uri@PDA for gout wound ulceration according to (i) uric acid reduction, (ii) antibacterial activity, and (iii) anti‐inflammatory effects.
Yonglan Yang, Yang Yang, Pengpeng Ma, Ruiqi Zhu, Xia Pan, Shaoling Zheng, Bo Chen, Yanli Jin, Youcong Gong, Jie Liu, Tianwang Li, Xu Chen   +11 more
wiley   +1 more source

Context-Adaptive Multimodal Inception Network With Aquila Optimization For Automated Rheumatic Heart Disease Classification

Jagadesh Arakere Nagaraj
openalex   +2 more sources